What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
William R. Hiatt mainly focuses on Internal medicine, Claudication, Physical therapy, Vascular disease and Intermittent claudication.
His Internal medicine research includes elements of Diabetes mellitus, Surgery and Cardiology.
His Claudication research is multidisciplinary, incorporating perspectives in Strength training and Physical medicine and rehabilitation.
He combines subjects such as Clinical trial, Disease, Quality of life and Intensive care medicine with his study of Physical therapy.
The various areas that he examines in his Vascular disease study include Pathophysiology and Risk factor.
William R. Hiatt has included themes like Anesthesia, Placebo, Cilostazol, Physical exercise and Bypass surgery in his Intermittent claudication study.
His most cited work include:
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) (5684 citations)
- Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care (2185 citations)
- Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: A meta-analysis (1342 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Surgery, Arterial disease and Claudication.
His work in the fields of Internal medicine, such as Disease, Myocardial infarction, Peripheral and Vascular disease, intersects with other areas such as In patient.
His biological study spans a wide range of topics, including Diabetes mellitus and Blood pressure.
His work deals with themes such as Hemodynamics and Skeletal muscle, which intersect with Surgery.
The study incorporates disciplines such as Intermittent claudication, Treadmill, Physical therapy, Randomized controlled trial and Placebo in addition to Claudication.
His studies in Physical therapy integrate themes in fields like Clinical trial, Quality of life and Physical medicine and rehabilitation.
He most often published in these fields:
- Internal medicine (50.41%)
- Cardiology (32.04%)
- Surgery (23.88%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (50.41%)
- Cardiology (32.04%)
- Arterial disease (22.86%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Cardiology, Arterial disease, Disease and In patient are his primary areas of study.
His study in Internal medicine concentrates on Myocardial infarction, Ticagrelor, Hazard ratio, Revascularization and Mace.
His study in Revascularization is interdisciplinary in nature, drawing from both Peripheral and Rivaroxaban.
His Cardiology research is multidisciplinary, incorporating elements of Amputation and Kidney disease.
In the subject of general Arterial disease, his work in Peripheral artery disease, Lower extremity revascularization and Claudication is often linked to Association, thereby combining diverse domains of study.
His research in Disease tackles topics such as Incidence which are related to areas like Specialty, Statin and MEDLINE.
Between 2017 and 2021, his most popular works were:
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. (130 citations)
- Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness (114 citations)
- Rivaroxaban in Peripheral Artery Disease after Revascularization (112 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
William R. Hiatt focuses on Internal medicine, Cardiology, Myocardial infarction, Hazard ratio and Revascularization.
Many of his studies involve connections with topics such as Amputation and Internal medicine.
His study explores the link between Cardiology and topics such as Clinical trial that cross with problems in Limb ischemia, Clinical events and Pharmacology.
His studies in Myocardial infarction integrate themes in fields like Platelet aggregation inhibitor and Clinical endpoint.
In his study, which falls under the umbrella issue of Revascularization, Post-hoc analysis, Lower risk and Risk factor is strongly linked to Proportional hazards model.
William R. Hiatt has researched Disease in several fields, including Treatment outcome, Intermittent claudication, Arterial disease and Emergency medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
